CANOPY GROWTH CORP COM NPV (OTCMKTS:TWMJF) Charging Hard in September

CANOPY GROWTH CORP COM NPV (OTCMKTS:TWMJF) Charging Hard in September

SHARE

CANOPY GROWTH CORP COM NPV (OTCMKTS:TWMJF) is one of the big cash plays in the Canadian MMJ market segment. TWMJF has been on fire in recent action, up nearly 75% since mid-June. The most recent catalyst for TWMJF is its introduction of Spectrum Cannabis to the Canadian medical cannabis market.

According to the release, “the new Canadian brand identity, already launched in several jurisdictions around the world, is a progression of the Mettrum Spectrum and is inspired by the industryfirst strain classification system which simplifies the dialogue around strength and dosage by categorizing medical cannabis according to THC and CBD levels, using a straightforward colour-coded guide.”

CANOPY GROWTH CORP COM NPV (OTCMKTS:TWMJF) is one of the bigger growers. The company produces and sells medical marijuana in Canada. It offers dry cannabis and oil products primarily under the Tweed and Bedrocan brands. It also sells its products through online.

According to company materials, “Tweed is the most recognized marijuana production brand in the world. It has built a large and loyal following by focusing on quality products and meaningful customer relationships. Tweed doesn’t just sell marijuana, it facilitates a conversation about a product we’ve all heard about but haven’t met intimately yet. It is approachable and friendly, yet reliable and trusted. As marijuana laws liberalize around the world, Tweed will expand its leading Canadian position around the globe.”

Also from their materials, “Bedrocan is the epitome of medical-grade cannabis. Bedrocan BV pioneered medical cannabis in Holland through decades of selection and refinement, leading to standardized, whole bud cannabis strains that patients can rely on. Bedrocan Canada supplies the same standardized strains to the Canadian market through exclusive licensing rights to the American continents, an arrangement it will also enjoy for all future genetic advancements. Due to its consistency over time, Bedrocan’s strains have been used in clinical research in seven European countries. That commitment to research didn’t stay on the east side of the Atlantic – Bedrocan Canada recently launched one of the largest clinical cannabis studies in the world, the EQUAL Study, to evaluate quality of life before and after medical cannabis use.”

Find out when TWMJF stock reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.

As discussed above, TWMJF has been on a roll of late, stringing together a very consistent streak of positive swings over the past couple months. That momentum was augmented this week by the company’s move to introduce Spectrum Cannabis, which is a new brand identity.

According to the press release, “in place since 2014 under the Mettrum brand, the Spectrum has been well received by the medical community and equally adopted by customers who regularly shop by Spectrum. The rebranding of Mettrum Health to Spectrum Cannabis in Canada is the natural progression of this methodology and will ensure a consistent and recognizable global brand across all federally legal jurisdictions where Canopy Growth operates.”

“Our mission at Canopy Growth has always been to simplify the conversation around medical cannabis, and with the Spectrum we have done just that,” said Mark Zekulin, President of Canopy Growth Corporation. “We’re also reinforcing the global nature of our operations by bringing the international-facing medical brand back home to Canada.”

Recent action has seen 30% tacked on to share pricing for the listing in the past month. This is emblematic of the stock. TWMJF has evidenced sudden upward volatility on many prior occasions. What’s more, the stock has registered increased average transaction volume recently, with the past month seeing above 110% above its longer run average levels.

Currently trading at a market capitalization of $1.5B, TWMJF has a significant war chest ($116M) of cash on the books, which must be weighed relative to about $1.7M in total current liabilities. One should also note that debt has been growing over recent quarters. TWMJF is pulling in trailing 12-month revenues of $48.8M. In addition, the company is seeing major top line growth, with y/y quarterly revenues growing at 127.3%. We will update the story again soon as further details emerge. Sign-up for continuing coverage on shares of $TWMJF stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in $TWMJF, either long or short, and we have not been compensated for this article.

Sign Up for our 100% FREE Oracle Dispatch Newsletter